Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer

NCT01950182 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

392

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Endocrine therapy combined with trastuzumab
DRUG: Chemotherapy combined with trastuzumab

Sponsor

Sun Yat-sen University